Publication
Dakin's Solution in the Treatment of Severe Diabetic Foot Infections
dc.contributor.author | Duarte, B | |
dc.contributor.author | Formiga, A | |
dc.contributor.author | Neves, J | |
dc.date.accessioned | 2022-04-22T14:34:38Z | |
dc.date.available | 2022-04-22T14:34:38Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Acute necrotising diabetic foot (DF) infections are common, costly, and do not infrequently result in debilitating major lower-extremity amputations. Dakin's solution is a long-standing topical antiseptic that has shown benefit in this clinical setting, but its use is undermined by a presumed risk of cytotoxicity. In this single-centre case series, we retrospectively evaluated 24 patients with severe necrotising DF infections treated with a cyclical instillation of Dakin's solution at a referral multidisciplinary DF unit. Most patients achieved favourable outcomes in infection control and limb salvage, with only one patient (4.2%) requiring a major (at or above-the-ankle) amputation. The mean time to complete or near-complete wound granulation was 5.4 weeks. Of the 12 patients who completed 12 or more months of longitudinal follow up, only 2 (12.2%) had a wound recurrence. In this severe DF infection patient cohort, Dakin's solution led to a clinically meaningful improvement. No remarkable impairment in the wound-healing process was observed. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Int Wound J. 2020 Apr;17(2):277-284. | pt_PT |
dc.identifier.doi | 10.1111/iwj.13268. | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4045 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.subject | HSAC DER | pt_PT |
dc.subject | HCC CIR | pt_PT |
dc.subject | Adult | pt_PT |
dc.subject | Aged | pt_PT |
dc.subject | Administration, Topical | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Aged, 80 and over | pt_PT |
dc.subject | Middle Aged | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Diabetic Foot / complications* | pt_PT |
dc.subject | Diabetic Foot / drug therapy | pt_PT |
dc.subject | Disinfectants / therapeutic use | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Follow-Up Studies | pt_PT |
dc.subject | Limb Salvage / methods* | pt_PT |
dc.subject | Retrospective Studies | pt_PT |
dc.subject | Severity of Illness Index | pt_PT |
dc.subject | Sodium Hypochlorite / therapeutic use* | pt_PT |
dc.subject | Treatment Outcome | pt_PT |
dc.subject | Wound Healing / drug effects* | pt_PT |
dc.subject | Wound Infection / diagnosis | pt_PT |
dc.subject | Wound Infection / drug therapy* | pt_PT |
dc.subject | Wound Infection / etiology | pt_PT |
dc.title | Dakin's Solution in the Treatment of Severe Diabetic Foot Infections | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 284 | pt_PT |
oaire.citation.startPage | 277 | pt_PT |
oaire.citation.title | International Wound Journal | pt_PT |
oaire.citation.volume | 17 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1